drugset / Trial / NCT05421013
Study to Evaluate Safety, Efficacy of Intralesional Injection of STP705 in Adults With Facial isSCC
Non-randomizedSequentialOpen-labelTreatment
Summary
Open label, dose escalation to evaluate safety.
Timeline
- Start
- 2022-08-01
- Primary completion
- 2023-03-29
- Completion
- 2023-03-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | STP705 | Small interfering RNA (siRNA) | 30 ug | Other |
| Subject | STP705 | Small interfering RNA (siRNA) | 60 ug | Other |
| Subject | STP705 | Small interfering RNA (siRNA) | 90 ug | Other |